6451 - 6460 of 7730 Results
Title
Year
- Interactions between misfolded protein oligomers and membranes: A central topic in neurodegenerative diseases?2015RESTRICTEDTitle: Interactions between misfolded protein oligomers and membranes: A central topic in neurodegenerative diseases?Journal Name: Biochimica et Biophysica Acta (BBA) - BiomembranesPublisher: Elsevier BVVol: 1848Issue #: 9Start Page: 1897End Page: 1907Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbamem.2015.01.018Citation Count: 94
- Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats2015RESTRICTEDTitle: Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 303Issue #:Start Page: 569End Page: 576Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.016Citation Count: 39
- Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice2015RESTRICTEDTitle: Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned miceJournal Name: NeurosciencePublisher: Elsevier BVVol: 303Issue #:Start Page: 586End Page: 594Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.032Citation Count: 12
- NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat2015RESTRICTEDTitle: NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in ratJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 271Issue #:Start Page: 335End Page: 350Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2015.05.021Citation Count: 65
-
RESTRICTEDTitle: The D3 dopamine receptor: From structural interactions to functionJournal Name: European NeuropsychopharmacologyPublisher: Elsevier BVVol: 25Issue #: 9Start Page: 1462End Page: 1469Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.euroneuro.2014.11.021Citation Count: 38
-
RESTRICTEDTitle: tranSMART Foundation Datathon 1.0: The cross neurodegenerative diseases challengeJournal Name: Applied & Translational GenomicsPublisher: Elsevier BVVol: 6Issue #:Start Page: 42End Page: 44Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.atg.2015.08.004Best OA location URL: https://doi.org/10.1016/j.atg.2015.08.004Citation Count: 7
-
RESTRICTEDTitle: Genome-wide variant by serum urate interaction in Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 78Issue #: 5Start Page: 731End Page: 741Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24504Citation Count: 8
- Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening2015RESTRICTEDTitle: Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug ScreeningJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 10Issue #: 8Start Page: e0136930End Page: e0136930Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0136930Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0136930&type=printableCitation Count: 19
- Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson’s disease2015RESTRICTEDTitle: Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson’s diseaseJournal Name: Experimental & Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 47Issue #: 8Start Page: e179End Page: e179Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/emm.2015.54Best OA location URL: https://www.nature.com/articles/emm201554.pdfCitation Count: 27
- Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation2015RESTRICTEDTitle: Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutationJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0038-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0038-3Citation Count: 92